计算溶液所需的质量、体积或浓度。
This is a demo store. No orders will be fulfilled.
| 货号 (SKU) | 包装规格 | 是否现货 | 价格 | 数量 |
|---|---|---|---|---|
| I412337-1mg |
1mg |
现货 ![]() |
| |
| I412337-5mg |
5mg |
现货 ![]() |
| |
| I412337-25mg |
25mg |
现货 ![]() |
| |
| I412337-50mg |
50mg |
现货 ![]() |
|
| 别名 | 伊那吉韦索普西 |
|---|---|
| 英文别名 | (((((2R,3S,5R)-5-(6-amino-9H-purin-9-yl)-3-hydroxytetrahydrofuran-2-yl)methoxy)(((2R,3R,4R,5R)-5-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)-2-(hydroxymethyl)-4-methoxytetrahydrofuran-3-yl)oxy)phosphoryl)thio)methyl isopropyl carbonate | AKOS032944878 | Ina |
| 规格或纯度 | ≥97% |
| 英文名称 | Inarigivir soproxil |
| 生化机理 | Inarigivir soproxil(GS 9992,SB 9200)是一种先天性免疫口服激动剂,据信可通过激活 RIG-I 和 NOD2 途径发挥作用。Inarigivir soproxil 对 RNA 病毒具有广谱抗病毒活性,对 HCV 1a 和 HCV 1b 的 EC50 分别为 2.2 μM 和 1.0 μM。 |
| 储存温度 | -20°C储存 |
| 运输条件 | 超低温冰袋运输 |
| 作用类型 | 抑制剂 |
| 产品介绍 |
Information Inarigivir soproxil Inarigivir soproxil (GS 9992, SB 9200) is an oral agonist of innate immunity that is believed to act via the activation of the RIG-I and NOD2 pathways. Inarigivir soproxil has broad-spectrum antiviral activity against RNA viruses with EC50 of 2.2 μM and 1.0 μM for HCV 1a and HCV 1b. |
| 纯度 | ≥97% |
| 作用机制 | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | 参考文献 |
|---|
| 分子类型 | 小分子 |
|---|---|
| IIUPAC Name | [[(2R,3S,5R)-5-(6-aminopurin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-[(2R,3R,4R,5R)-5-(2,4-dioxopyrimidin-1-yl)-2-(hydroxymethyl)-4-methoxyoxolan-3-yl]oxyphosphoryl]sulfanylmethyl propan-2-yl carbonate |
| INCHI | 1S/C25H34N7O13PS/c1-12(2)42-25(37)40-11-47-46(38,45-19-14(7-33)44-23(20(19)39-3)31-5-4-16(35)30-24(31)36)41-8-15-13(34)6-17(43-15)32-10-29-18-21(26)27-9-28-22(18)32/h4-5,9-10,12-15,17,19-20,23,33-34H,6-8,11H2,1-3H3,(H2,26,27,28)(H,30,35,36)/t13-,14+,15+,17+,19+,20+,23+,46?/m0/s1 |
| InChi Key | CJCYTUJOSMYXLE-JDLSZIHUSA-N |
| Smiles | CC(C)OC(=O)OCSP(=O)(OCC1C(CC(O1)N2C=NC3=C(N=CN=C32)N)O)OC4C(OC(C4OC)N5C=CC(=O)NC5=O)CO |
| Isomeric SMILES | CC(C)OC(=O)OCSP(=O)(OC[C@@H]1[C@H](C[C@@H](O1)N2C=NC3=C(N=CN=C32)N)O)O[C@@H]4[C@H](O[C@H]([C@@H]4OC)N5C=CC(=O)NC5=O)CO |
| 分子量 | 703.62 |
| Reaxy-Rn | 26423187 |
| Reaxys-RN link address | https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN=26423187&ln= |
| 溶解性 | Solubility (25°C) In vitro DMSO: 100 mg/mL (142.12 mM); Ethanol: 60 mg/mL (85.27 mM); Water: 25 mg/mL (35.53 mM); |
|---|---|
| 分子量 | 703.600 g/mol |
| XLogP3 | -1.800 |
| 氢键供体数Hydrogen Bond Donor Count | 4 |
| 氢键受体数Hydrogen Bond Acceptor Count | 18 |
| 可旋转键计数Rotatable Bond Count | 15 |
| 精确质量Exact Mass | 703.167 Da |
| 单同位素质量Monoisotopic Mass | 703.167 Da |
| 拓扑极表面积Topological Polar Surface Area | 284.000 Ų |
| 重原子数Heavy Atom Count | 47 |
| 形式电荷Formal Charge | 0 |
| 复杂度Complexity | 1220.000 |
| 同位素原子数Isotope Atom Count | 0 |
| 定义的原子立体中心计数Defined Atom Stereocenter Count | 7 |
| 未定义的原子立体中心计数Undefined Atom Stereocenter Count | 1 |
| 定义的键立体中心计数Defined Bond Stereocenter Count | 0 |
| 未定义的键立体中心计数Undefined Bond Stereocenter Count | 0 |
| 所有立体化学键的总数The total count of all stereochemical bonds | 0 |
| 共价键合单元计数Covalently-Bonded Unit Count | 1 |
¥299.90